(Date:11/25/2009)...25 Biotech firm Replikins Ltd., wh... the 1918 pandemic through the prediction, outbrea...y issued its latest biochemical analysis of the vi...H1N1 ("Swine Flu") virus has dropped from its peak...reak in the spring of 2009 to resting non-epidemic...
(Date:11/25/2009)... Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd....nes, announced today that it executed,a joint vent...accine,Technology Co., Ltd. (Sinovac Dalian). The ...ze human-use vaccines. Sinovac will contribute its...cializing world-class vaccines; the,other party wi...
(Date:11/24/2009)...4 IES (Nasdaq: IESC ), ...unications systems and services for the commercial...day that its commercial business group has been aw...ll the electrical systems for the Level 4 bio-safe...my Medical Research Institute of Infectious Diseas...
(Date:11/24/2009)...M, Ontario, Nov. 24 Dow ...g the assets of Hyland Seeds, a division of Thomps...Hyland Seeds will further expand Dow AgroSciences,... the introduction of SmartStax(TM) in 2010 a...ology in corn in 2012. The transactional close is ...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3...DL ) a,leading, global full-service clinical resea...Higginbotham will participate in the annual Raymon...erence will be held at The State,Room, 60 State St...le,s,presentation is scheduled from 2:30 to 3:15 p.../www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO...
...vice Options (FCSO) has selected Burgess, recogniz... solutions, to support a new Medicare contract awa...dicaid Services (CMS). , , Under this new con...ginning Jan. 1, 2009 between health care providers...or-Service (PFFS) plans. FCSO will license and em...
...rmaceuticals, Inc.,today announced positive result...ety and efficacy of its lead product candidate, AR...tient acute pain following knee replacement surger...Sum of the Pain Intensity,Difference - SPID12) ove...esults demonstrated that compared to placebo, pati...
Other Biology Technology:Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference 2FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract 2AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain 2AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain 3PCNA Immunohistochemistry Assay Kit from Invitrogen
dNTP Set from Invitrogen
Rabbit Anti-Human WNT1 Monoclonal Antibody, Clone ZMD.326 from Invitrogen
Nick Translation System from Invitrogen
Biology Products: